Doctor profile · Federal record

Dr. Brian Dicarlo, MD

Hematology & Oncology Physician (CMS: Medical Oncology) · San Luis Obispo, CA

  • NPI 1982728796
  • Accepts Medicare
  • MIPS 84.9 / 100 · 2023
  • 25 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
892 Aerovista Pl Ste 240
San Luis Obispo, CA 934018054
(805) 541-8252
fax (805) 543-8252
Mailing address
5767 W Century Blvd Ste 400
Los Angeles, CA 900455631

Credentials & registration

NPPES · NUCC
NPI registered
March 2007 — 19 yrs on file
Profile last updated
September 23, 2019
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A98389

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1982728796. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
250,151
Distinct HCPCS
10
Medicare allowed
$5,968,875
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 37,400 33 $54
J9299 Injection, nivolumab, 1 mg 31,384 19 $30
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 30,240 18 $48
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 27,030 18 $0
J0897 Injection, denosumab, 1 mg 18,480 57 $23
J9263 Injection, oxaliplatin, 0.5 mg 18,400 16 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 17,500 14 $3
J1453 Injection, fosaprepitant, 1 mg 16,650 37 $0
J9267 Injection, paclitaxel, 1 mg 16,242 19 $0
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 6,290 13 $29

In context: peer comparison

Among 4 peers in San Luis Obispo Hematology & Oncology Physician, average services per provider: 2,692. This provider delivers 93× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$421
Transactions
10
Manufacturers
7
Payer (manufacturer) Industry Txns Amount
Genmab U.S., INC. 1 $124.99
Abbvie INC. 1 $111.71
Pfizer INC. 3 $54.18
Abbott Laboratories 1 $46.28
Merck Sharp & Dohme LLC 2 $37.02
E.R. Squibb & Sons, L.L.C. 1 $24.63
Medtronic, INC. 1 $21.91

By nature of payment

Food and Beverage
$421

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
920
Patients
351
Total drug cost
$864,614
Drug Type Claims Patients Total cost
Letrozole Generic 132 41 $4,443
Prednisone Generic 129 47 $1,320
Ondansetron Hcl Generic 80 57 $1,583
Tamoxifen Citrate Generic 72 24 $2,840
Abiraterone Acetate Generic 71 12 $126,944
Anastrozole Generic 70 19 $2,114
Hydrocortisone Generic 55 21 $1,932
Dexamethasone Generic 46 31 $1,280
Omeprazole Generic 46 18 $1,109
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 43 26 $1,115

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Brian Dicarlo's medical specialty?
Dr. Brian Dicarlo practices Hematology & Oncology Physician in San Luis Obispo, CA.
Where does Dr. Brian Dicarlo practice?
Dr. Brian Dicarlo practices at 892 Aerovista Pl Ste 240, San Luis Obispo, CA 934018054. Office phone: 8055418252.
What is Dr. Brian Dicarlo's NPI?
Dr. Brian Dicarlo's National Provider Identifier (NPI) is 1982728796, issued by NPPES.
Does Dr. Brian Dicarlo accept Medicare assignment?
Yes. Dr. Brian Dicarlo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brian Dicarlo commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.